Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
24-Aug-2026 | 740.05 | 780.85 | 737 | 770.35 | 25,911 | 37,39,50,565.75 | 2,32,673 |
25-Aug-2026 | 776.5 | 783 | 744 | 745.05 | 14,621 | 18,59,45,458.6 | 1,27,362 |
26-Aug-2026 | 752 | 773.8 | 750 | 766.1 | 27,212 | 31,55,07,780.45 | 2,33,178 |
27-Aug-2026 | 769 | 778.05 | 760 | 761.2 | 17,844 | 27,57,51,738.4 | 2,01,182 |
28-Aug-2026 | 764 | 774.45 | 758.6 | 772.6 | 18,171 | 31,35,70,425.15 | 2,41,675 |
31-Aug-2026 | 776.15 | 785 | 768.9 | 776.7 | 13,367 | 20,08,68,772.3 | 1,27,139 |
01-Sep-2026 | 780.5 | 796.55 | 771.3 | 779.05 | 21,314 | 36,14,22,563.6 | 2,35,869 |
02-Sep-2026 | 778 | 794.9 | 768.2 | 770.25 | 27,882 | 58,29,86,947.7 | 4,69,258 |
03-Sep-2026 | 764.35 | 788 | 760.5 | 780.55 | 18,333 | 26,06,96,968.15 | 1,81,987 |
04-Sep-2026 | 784.4 | 785 | 748.35 | 765.75 | 21,239 | 25,79,09,160.65 | 1,74,108 |
07-Sep-2026 | 765.75 | 772.9 | 751.5 | 754.65 | 8,564 | 9,18,48,258.15 | 62,476 |
08-Sep-2026 | 754.05 | 757.75 | 733.15 | 736.6 | 11,470 | 14,73,55,529 | 1,18,782 |
09-Sep-2026 | 737 | 769 | 737 | 741.1 | 21,459 | 32,54,13,409.15 | 2,22,641 |
10-Sep-2026 | 741.1 | 755.1 | 740.35 | 749.65 | 42,931 | 21,72,43,505.85 | 1,71,702 |
11-Sep-2026 | 753 | 784.4 | 740.5 | 776.35 | 20,842 | 30,74,93,068 | 1,72,242 |
15-Sep-2026 | 780.25 | 792 | 762.15 | 765.65 | 26,631 | 26,83,52,832.65 | 1,69,964 |
16-Sep-2026 | 759.2 | 775 | 746.4 | 772 | 13,214 | 18,03,03,375.7 | 1,25,128 |
17-Sep-2026 | 768.1 | 789.35 | 763.9 | 766.7 | 13,506 | 16,68,77,645.8 | 1,20,626 |
18-Sep-2026 | 767.1 | 790 | 767.1 | 783.7 | 24,523 | 25,73,85,129.15 | 2,03,792 |
21-Sep-2026 | 785 | 830 | 779.7 | 821.45 | 39,953 | 67,58,20,516.25 | 3,06,314 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
